Skip to content

News

Highlights

IPI’s community-centered approach to antibody discovery: A Q&A with Rob Meijers

This spring, the Institute for Protein Innovation (IPI) dispatched a collection of antibodies targeting members of the elusive integrin receptor family. Those antibodies, shared with...

Read more

Cell signaling, Sonic Hedgehog and Hemingway’s cats: A Q&A with Adrian Salic

In 1980, the famous geneticists Christiane Nüsslein-Volhard and Eric Wieschaus were mapping embryonic mutations in the model organism Drosophila melanogaster, known colloquially as the fruit...

Read more

IPI antibody helps illuminate the MYCN-mediated tumor microenvironment

If you were diagnosed with aggressive neuroblastoma, you’d most likely be an infant carrying a genetic change that sprang up in your nerve cells before...

Read more
“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

In 1984, Lewis “Rusty” Williams boarded a flight from Boston to San Francisco and took the last open seat near the back of the plane....

Read more
A group of people sit around a conference room table with laptops and water bottles on the tabletop. André Teixeira sits at the head of the table, smiling.

Engineering for efficiency: André Teixeira takes charge of antibody discovery and library design at IPI

It’s a few minutes after noon, and scientists at the Institute for Protein Innovation (IPI) are eating in the conference room. The conversation turns to IPI’s antibody display library —…

A digital rendering of neurotransmission in the synapse, shown with glowing neurons flowing at a synaptic connection.

Entry points into neuroscience: A Q&A with Thomas Biederer

At the heart of all nervous system functions are the synapses, where signals fly between neurons in swarms of molecular activity. Thomas Biederer is intent on prying open the compartments’…

Auro Nair and his family crowd into a photo, all smiles.

For IPI Board member Auro Nair, biotech is an outlet for good

Growing up in Malaysia, Auro Nair learned two basic tenets from his parents: Be a good person and do well in school. These maxims may have seemed simplistic to a…

Image shows the growing axon of a mouse dorsal root ganglion sensory neuron in vitro turning away from the extracellular signaling molecule WFIKKN2.

Dissecting the nervous system’s self-assembly toolkit: A Q&A with Alex Jaworski

Early in development, an embryo begins an epic undertaking: the building of its nervous system. As part of the process, neurons send out axons on extraordinary journeys to distant targets.…

Issi Rozen playing his guitar and leaning against a distressed brick wall.

Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board

Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is followed by hours of practice to learn scales and complex harmonies, decades of determination to…

Crowd listens to six researchers discuss antibody access and reproducibility on a small stage.

At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility

In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools would be affordable, proffered…

Three photos picturing Deepash Kothiwal working in the lab, Mahesh Vangala smiling in front of a computer with antibody data, and Nirakar Basnet looking at protein images.

IPI broadens scientific expertise with new talent

In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who’ve joined IPI from around the world,…

Two men talking in office building.

From president and CEO Ken Fasman: IPI in the midst of an exciting growth year

I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering, neuroscience and genomics, and…

IPI partnership with Addgene

The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents

Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…

Zebrafish lit up under microscopy with visible spine and colored spots marking proteins.

IPI antibody helps illuminate the MYCN-mediated tumor microenvironment

If you were diagnosed with aggressive neuroblastoma, you’d most likely be an infant carrying a genetic change that sprang up in your nerve cells before you were born. That change…

Crowd listens to six researchers discuss antibody access and reproducibility on a small stage.

At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility

In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools would be affordable, proffered…

New federation aims to transform biology with protein tools spanning proteome by 2035

New federation aims to transform biology with protein tools spanning proteome by 2035

An ambitious protein moonshot is gaining momentum to develop and widely share tools that will land us understanding of the complete human proteome. In 2003, biology was all about the…

A man in a lab

From Rob Meijers, interim executive director: In 2021, IPI explored ‘new frontiers’ in antigen and antibody discovery

As the world struggled to live in and through a seeming “forever pandemic,” 2021 was a year that demanded global resilience. The potency of delta followed by fast spread of…

A person holding a vial

Antibodies are going from biology’s workhorses to precision tools, a boon for reliable research

Roughly a decade ago, biologists conducting high-stakes experiments noticed a pattern: Many findings couldn’t be replicated in other labs, throwing doubt on data that should have led to treatments for…

Rob Meijers pictured in an IPI conefernce room, wearing a button-up shirt and laughing. Laptops are shown in the foreground.

IPI’s community-centered approach to antibody discovery: A Q&A with Rob Meijers

This spring, the Institute for Protein Innovation (IPI) dispatched a collection of antibodies targeting members of the elusive integrin receptor family. Those antibodies, shared with researchers around the world through…

The 3D structure of Sonic Hedgehog.

Cell signaling, Sonic Hedgehog and Hemingway’s cats: A Q&A with Adrian Salic

In 1980, the famous geneticists Christiane Nüsslein-Volhard and Eric Wieschaus were mapping embryonic mutations in the model organism Drosophila melanogaster, known colloquially as the fruit fly. They found that when…

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

In 1984, Lewis “Rusty” Williams boarded a flight from Boston to San Francisco and took the last open seat near the back of the plane. Williams, then a doctor and…

A group of people sit around a conference room table with laptops and water bottles on the tabletop. André Teixeira sits at the head of the table, smiling.

Engineering for efficiency: André Teixeira takes charge of antibody discovery and library design at IPI

It’s a few minutes after noon, and scientists at the Institute for Protein Innovation (IPI) are eating in the conference room. The conversation turns to IPI’s antibody display library —…

A digital rendering of neurotransmission in the synapse, shown with glowing neurons flowing at a synaptic connection.

Entry points into neuroscience: A Q&A with Thomas Biederer

At the heart of all nervous system functions are the synapses, where signals fly between neurons in swarms of molecular activity. Thomas Biederer is intent on prying open the compartments’…

Auro Nair and his family crowd into a photo, all smiles.

For IPI Board member Auro Nair, biotech is an outlet for good

Growing up in Malaysia, Auro Nair learned two basic tenets from his parents: Be a good person and do well in school. These maxims may have seemed simplistic to a…

Image shows the growing axon of a mouse dorsal root ganglion sensory neuron in vitro turning away from the extracellular signaling molecule WFIKKN2.

Dissecting the nervous system’s self-assembly toolkit: A Q&A with Alex Jaworski

Early in development, an embryo begins an epic undertaking: the building of its nervous system. As part of the process, neurons send out axons on extraordinary journeys to distant targets.…

Issi Rozen playing his guitar and leaning against a distressed brick wall.

Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board

Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is followed by hours of practice to learn scales and complex harmonies, decades of determination to…

Three photos picturing Deepash Kothiwal working in the lab, Mahesh Vangala smiling in front of a computer with antibody data, and Nirakar Basnet looking at protein images.

IPI broadens scientific expertise with new talent

In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who’ve joined IPI from around the world,…

Two men talking in office building.

From president and CEO Ken Fasman: IPI in the midst of an exciting growth year

I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering, neuroscience and genomics, and…

Scientist viewing robot in lab.

Engineering Protein A to Z for VH3 antibody purification

Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody production at the Institute…

Hand holding pipette and tube.

Inside the IPI pipeline

Of the tools underpinning biomedical research, antibodies are among the most impactful. Their ability to recognize and attach to biomolecules has powered fundamental discoveries, diagnostic methods and treatments for diseases,…

IPI partnership with Addgene

The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents

Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…

Man in office lined with awards.

Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation

The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools and expertise BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI), a nonprofit…

Feature photo announcing IPI Surfacing, a symposium on June 15, 2023 from 8 a.m. to 6:30 p.m. at the Joseph B. Martin Conference Center.

Institute for Protein Innovation welcomes top researchers at first symposium

BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long…

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman,  Ph.D. as president and chief executive officer

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman, Ph.D. as president and chief executive officer

Boston, November 15, 2022 — The Institute for Protein Innovation (IPI), a nonprofit research organization advancing protein science to accelerate biomedical research and improve human health, today announced the appointment…

A man pointing to a computer screen

AI Proteins secures $18.2 million seed round to pioneer high-throughput platform for advanced miniprotein therapeutics

Company to focus on the rapid development of miniproteins tailor-made for therapeutics, driving down costs and shortening the time required to develop safer, more effective medicines. BOSTON—(BUSINESS WIRE)—AI Proteins, the…

IPI joins an exciting effort to solve the reproducibility crisis

IPI joins an exciting effort to solve the reproducibility crisis

IPI is thrilled to join YCharOS as a member of its new Industry Advisory Committee. The Canadian company, named from a truncation of Antibody Characterization through Open Science, is launching…

Christopher Bahl selected as a TED Fellow

Christopher Bahl selected as a TED Fellow

Institute for Protein Innovation Head of Protein Design to present at TED2019, joining the newest class of 20 global visionaries. BOSTON, Jan. 23, 2019 /PRNewswire/ — Molecular Engineer Chris Bahl…

IPI appoints Wei Yang as director of target discovery and Sharon Klein as director of philanthropy

IPI appoints Wei Yang as director of target discovery and Sharon Klein as director of philanthropy

Boston, June 26, 2018 /PR Newswire/ – Institute for Protein Innovation (IPI), a non-profit research organization focused on empowering research in protein science and developing open-source monoclonal antibodies, announced today…

IPI relocates to Boston’s Longwood Medical and Academic Area

IPI relocates to Boston’s Longwood Medical and Academic Area

BOSTON, May 21, 2018 /PRNewswire/ — Just one year after launch, IPI has relocated to the Harvard Institutes of Medicine at 4 Blackfan Circle, Boston. The 12,000-square-foot lab space represents a dramatic expansion and…

Get in touch today

Back To Top